Rethinking clinical trials

Science

Volumn 333, Issue 6050, 2011, Pages 1679-

  Grove, Andrew ^a,b  

^a INTEL CORPORATION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); DRUG MARKETING; EDITORIAL; ELECTRONIC COMMERCE; FOOD AND DRUG ADMINISTRATION; HUMAN; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; UNITED STATES;

EID: 80053135173     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1212118     Document Type: Editorial

References (3)

1. H. Hvitfeldt et al., Qual. Manag. Health Care 18, 247 (2009).
2. B. J. Madden, Free to Choose Medicine (Heartland Institute, Chicago, IL, 2010).
3. M. Boldrin, S. J. Swamidass, "A New Bargain for Drug Approvals," Wall Street Journal, 25 July 2011.